Alzheimer’s disease threatens lives. Our research can help save them.

Alzheimer’s disease doesn’t just steal memories. It steals the lives of people we love. Chances are, you know people who have been affected by Alzheimer’s. And the numbers keep growing.

But Baylor College of Medicine’s Center for Alzheimer’s and Neurodegenerative Diseases (CAND) is changing the future of Alzheimer’s and other neurodegenerative diseases. We’re working to give people better health — and families more hope.

At CAND, we’re pioneering the development of personalized approaches for diagnostics, risk prediction and ultimately treatment for and prevention of Alzheimer’s, Parkinson’s, Lou Gehrig’s disease (ALS) and other devastating conditions.

As a vital hub for interdisciplinary research affiliated with the largest medical center in the world, we’re uniquely positioned to turn new research-driven discoveries into treatments that benefit patients near and far.

Supported by caring people like you, we’re leading the way toward a day when these life-threatening conditions no longer put any of our loved ones at risk.

Through cutting-edge research, cross-disciplinary partnerships and direct patient care, we’re advancing how we understand the unique interactions between genes, lifestyle and other factors that can trigger forms of neurodegeneration — and then applying these insights to targeted therapies designed to meet the needs of each patient.

As Dr. Shulman says, “We’re trying to push the envelope of completely new treatment approaches that we think are going to hopefully cure this disease and better protect people against it in the years ahead.”

But millions are at risk. The more we we can accelerate research and clinical testing, the sooner we can develop potential new therapies that will improve the quality of life for Americans living with neurodegenerative diseases.